INTERNATIONAL PATENT: SHANGHAI PHRONTLINE BIOPHARMA CO., LTD, 上海拓济医药有限责任公司 FILES APPLICATION FOR "ERIBULIN DERIVATIVE AND ANTIBODY-DRUG CONJUGATE THEREOF AND MEDICAL USE THEREOF"

GENEVA, Nov. 10 -- SHANGHAI PHRONTLINE BIOPHARMA CO., LTD (Room 502, Building 1, Unit B, No. 1976 Gaoke Zhong RoadPudong New Area, Shanghai 201210), 上海拓济医药有限责任公司 (中国上海市浦东新区高科中路1976号1幢B座502室) filed a patent application (PCT/CN2025/090154) for "ERIBULIN DERIVATIVE AND ANTIBODY-DRUG CONJUGATE THEREOF, AND MEDICAL USE THEREOF" on Apr 21, 2025. With publication no. WO/2025/228172, the details related to the patent application was published on Nov 06, 2025.

Notably, the patent application was submitted under the International Patent Classificatio...